Literature DB >> 19047230

Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study.

Bart E van Ewijk1, Marieke M van der Zalm, Tom F W Wolfs, Andre Fleer, Jan L L Kimpen, Berry Wilbrink, Cornelis K van der Ent.   

Abstract

OBJECTIVE: We aimed to investigate differences in upper and lower respiratory tract symptoms in relation to respiratory viral infections detected with polymerase chain reaction assays in young children with cystic fibrosis and healthy control subjects.
METHODS: In a 6-month winter period, 20 young children with cystic fibrosis and 18 age-matched, healthy, control subjects were contacted twice per week for detection of symptoms of an acute respiratory illness. If any symptom was present, then a home visit was made for physical examination and collection of nasopharyngeal swabs for viral analysis. In addition, parents were instructed to collect nasopharyngeal swabs every 2 weeks.
RESULTS: Children with cystic fibrosis and healthy control subjects had similar frequencies of acute respiratory illnesses (3.8+/-1.0 and 4.2+/-1.7 episodes, respectively). Although there were no significant differences in upper respiratory tract symptoms, the children with cystic fibrosis had longer periods of lower respiratory tract symptoms (22.4+/-22.2 vs 12.8+/-13.8 days) and a higher mean severity score per episode (2.35+/-0.64 vs 1.92+/-0.46). In addition, similar increases in upper respiratory tract symptom scores were associated with significantly greater increases in lower respiratory tract symptom scores in children with cystic fibrosis. No differences in the seasonal occurrences and distributions of respiratory viruses were observed, with picornaviruses and coronaviruses being the most prevalent.
CONCLUSIONS: Although there were no differences in the seasonal occurrences and distributions of polymerase chain reaction-detected respiratory viruses, acute respiratory illnesses were frequently associated with increased lower respiratory tract morbidity in young children with cystic fibrosis.

Entities:  

Mesh:

Year:  2008        PMID: 19047230     DOI: 10.1542/peds.2007-3139

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  42 in total

Review 1.  Spectrum of viral infections in patients with cystic fibrosis.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

2.  Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells.

Authors:  Sangbrita S Chattoraj; Shyamala Ganesan; Andrew M Jones; Jennifer M Helm; Adam T Comstock; Rowland Bright-Thomas; John J LiPuma; Marc B Hershenson; Umadevi S Sajjan
Journal:  Thorax       Date:  2011-02-02       Impact factor: 9.139

Review 3.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 4.  Cystic fibrosis: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  Jessica E Pittman; Garry Cutting; Stephanie D Davis; Thomas Ferkol; Richard Boucher
Journal:  Ann Am Thorac Soc       Date:  2014-04

5.  Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosis.

Authors:  Constantina Boikos; Jesse Papenburg; Christine Martineau; Lawrence Joseph; David Scheifele; Mark Chilvers; Larry C Lands; Gaston De Serres; Caroline Quach
Journal:  Hum Vaccin Immunother       Date:  2017-03-08       Impact factor: 3.452

Review 6.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

7.  Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells.

Authors:  Sangbrita S Chattoraj; Shyamala Ganesan; Andrea Faris; Adam Comstock; Wai-Ming Lee; Umadevi S Sajjan
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

8.  Rhinovirus-induced barrier dysfunction in polarized airway epithelial cells is mediated by NADPH oxidase 1.

Authors:  Adam T Comstock; Shyamala Ganesan; Asamanja Chattoraj; Andrea N Faris; Benjamin L Margolis; Marc B Hershenson; Umadevi S Sajjan
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

9.  Chronic rhinovirus infection in an adult with cystic fibrosis.

Authors:  William G Flight; Rowland J Bright-Thomas; Peter Tilston; Kenneth J Mutton; Malcolm Guiver; A Kevin Webb; Andrew M Jones
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

Review 10.  Cystic fibrosis.

Authors:  Felix Ratjen; Scott C Bell; Steven M Rowe; Christopher H Goss; Alexandra L Quittner; Andrew Bush
Journal:  Nat Rev Dis Primers       Date:  2015-05-14       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.